CardioMech Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$17.6M
- Investors
-
4
CardioMech General Information
Description
Developer of catheter-based technology designed to provide an alternative to open-heart cardiac surgery. The company's therapy helps in the placement of artificial chords in the heart via a catheter to reduce or eliminate mitral regurgitation without opening the chest, stopping the heart, or going on a heart-lung bypass, enabling surgeons to treat patients with moderate to severe or severe symptomatic RMD.
Contact Information
Website
www.cardiomech.comCorporate Office
- Udbyes Gate 3a
- 7030 Trondheim
- Norway
Corporate Office
- Udbyes Gate 3a
- 7030 Trondheim
- Norway
CardioMech Timeline
CardioMech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 21-Apr-2025 | $17.6M | Completed | Clinical Trials - Phase 1 | ||
| 4. Later Stage VC | 02-Jan-2024 | Completed | Pre-Clinical Trials | |||
| 3. Later Stage VC | 16-Feb-2023 | Completed | Startup | |||
| 2. Later Stage VC | 29-Apr-2022 | $6.17M | $24.7M | Completed | Pre-Clinical Trials | |
| 1. Later Stage VC (Series A) | 04-Aug-2020 | $18.5M | $18.5M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
CardioMech Comparisons
Industry
Financing
Details
CardioMech Competitors (2)
One of CardioMech’s 2 competitors is CoreMedic, a Venture Capital-Backed company based in Radolfzell, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CoreMedic | Venture Capital-Backed | Radolfzell, Germany | ||||
| NeoChord | Venture Capital-Backed | Maple Grove, MN |
CardioMech Patents
CardioMech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026149910-A1 | Soft tissue anchor system for heart repair | Pending | 07-Jan-2025 | ||
| GB-202412828-D0 | Soft tissue anchor system for heart repair | Pending | 02-Sep-2024 | ||
| GB-2643765-A | Soft tissue anchor system for heart repair | Pending | 02-Sep-2024 | ||
| WO-2026047216-A1 | Soft tissue anchor system for heart repair | Pending | 02-Sep-2024 | ||
| AU-2024284932-A1 | Device for heart repair | Pending | 08-Jun-2023 | A61F2/2466 |
CardioMech Signals
CardioMech Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| The ECI Group | Venture Capital | Minority | ||
| Thornapple River Capital | Venture Capital | Minority | ||
| Hadean Ventures | Venture Capital | Minority | ||
| Investinor | Venture Capital | Minority |
CardioMech FAQs
-
When was CardioMech founded?
CardioMech was founded in 2015.
-
Where is CardioMech headquartered?
CardioMech is headquartered in Trondheim, Norway.
-
What is the size of CardioMech?
CardioMech has 9 total employees.
-
What industry is CardioMech in?
CardioMech’s primary industry is Surgical Devices.
-
Is CardioMech a private or public company?
CardioMech is a Private company.
-
What is CardioMech’s current revenue?
The current revenue for CardioMech is .
-
How much funding has CardioMech raised over time?
CardioMech has raised $59.2M.
-
Who are CardioMech’s investors?
The ECI Group, Thornapple River Capital, Hadean Ventures, and Investinor have invested in CardioMech.
-
Who are CardioMech’s competitors?
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process